跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 761 条关于
“Hangzhou Converd”
全部
761
临床试验
358
药物
188
机构
103
资讯
112
7个月前
Oncolytic Virus Therapy Pipeline Expands with 100+ Companies Developing Novel Cancer Treatments
2个月前
Altruist Biologics' Hangzhou ADC Facility Receives First Trilateral Provincial Regulatory Approval for Segmented Manufacturing
4个月前
LQR House Partners with Hangzhou GSY Biotechnology to Develop Functional Wellness Beverages Using Proprietary Fermentation Technology
上个月
Transcenta Sells Hangzhou CDMO Plant to WuXi Biologics for RMB 190 Million, Then Licenses HiCB Platform Back to the Buyer
去年
EVA Pharma Establishes Eighth Global Office in Hangzhou's BioPharma Town to Advance Cell and Gene Therapy Innovation
上个月
Shanghai Industry Association Issues First-Ever Technical Standard for Plant-Derived Exosome-Like Nanovesicles
去年
WuXi Biologics Achieves Milestone with First Commercial PPQ Campaign at 15,000L Single-Use Bioreactor Facility
7个月前
Arctic Vision Acquires MDCO Technology's Ophthalmic Device Business to Create Integrated Drug-Device Platform
4个月前
AI Platform Identifies Traditional Chinese Medicine Compounds for Alzheimer's Disease Treatment
9个月前
Heidelberg Pharma Appoints Dr. Dongzhou Jeffery Liu as New CEO Amid Leadership Transition
第 1 页,共 12 页
上一页
下一页